Methods and compositions for the inhibition of gene expression

Details for Australian Patent Application No. 2012202547 (hide)

Owner Pronai Therapeutics, Inc.

Inventors Olson, David; Goodwin, Neal; Sooch, Mina Patel; Sheikhnehjad, Gholamreza

Agent Spruson & Ferguson

Pub. Number AU-A-2012202547

Parent 2005250453

Filing date 1 May 2012

Wipo publication date 24 May 2012

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12N 15/88 (2006.01) Mutation or genetic engineering

Event Publications

17 May 2012 Complete Application Filed

24 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202547

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202548-Header height control with closed center pump

2012202546-Encoding of rasterised graphic objects